Icon Plc News Today

Make it in America Brian set to Showcase Companies that not only are making their products here in the usa but theyre also making money doing it power lunch starts right now thats right, melissa break out the National Anthem and send in the eagles because were going to america this week all right. Stop me if youve heard this one before the dow hitting an alltime high on this final day in july. It has been a red hot month for your money the dow, s p and nasdaq all on track for their biggest gains...

Market OverviewThe Clinical Trial Imaging Market was valued at USD 1,150.5 Million in 2023 and projected to more than double to reach USD 2,219.8 Million by 2032. This market is expected to expand at a Compound Annual Growth Rate (CAGR) of 7.8% from 2023 to 2032. The substantial growth can be attributed to several f...

Real World Evidence Solutions Market by Component (Services, & Others), by End Users (Pharmaceutical and Medical Devices Companies, Other End Users), by Therapeutic area (Oncology, Cardiovascular, Others), by Region – Global Share and Forecast to 203

/PRNewswire/ -- The report titled "Clinical Trial Analytics Services Market by Services (Clinical Data Analytics, Clinical Trial Data Management, Clinical...

PUNE, India, April 30, 2024 /PRNewswire/ — The report titled “Clinical Trial Analytics Services Market by Services (Clinical Data Analytics, Clinical Trial Data Management, Clinical Trial Planning & Monitoring), Component (Data Management & Integrity Services, Data Visualization & Dashboarding, Patient Recruitment & Retention Analytics), Stages, End-User, Deployment – Global Forecast 2024-2030“ is now available on 360iResearch.com’s offering, [&hel...

Operator: Hello, and welcome to the ICON plc Q1 2024 Results Call. At this time, all participants are in a listen-only mode.

According to a recent report by Market.us, the Global Real World Evidence (RWE) Solutions Market size is expected to be worth around USD 5.8 Billion by 2033 from USD 2.7 Billion in 2023, growing at a CAGR of 7.9% during the forecast period from 2024 to 2033.An Increase in Demand and Opportunities for the Global Real...

The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

/PRNewswire/ -- The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and...

Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The